bioAffinity Technologies, Inc. BIAF
2.93 USD -0.26 (-8.15%)
At closeNov 4, 2026, 4:00 PM EST
2.93 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
2.93 Day range 3.22
2.66 52-week range 80.70
- YTD
- -83.45%
- 1 year
- -90.65%
Financial health
Altman Z-Score
-16.57 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E -0.1×
FY 2019 5y median -1.2× FY 2025
P/S 0.3×
FY 2019 5y median 1.2× FY 2025
P/B 0.3×
FY 2019 5y median 0.7× FY 2025
P/FCF -0.2×
FY 2019 5y median -1.7× FY 2025
EV/EBITDA 0.2×
FY 2019 5y median -1.4× FY 2025
EV/Sales -0.5×
FY 2019 5y median 0.0× FY 2025
FCF Yield -462.3%
FY 2019 5y median -59.6% FY 2025
Profitability
Gross Margin 23.2%
FY 2019 5y median 31.3% FY 2025
Operating Margin -171.6%
FY 2019 5y median -171.6% FY 2025
Net Margin -242.0%
FY 2019 5y median -242.0% FY 2025
ROE -204.9%
FY 2019 5y median -163.5% FY 2025
ROIC -125.3%
FY 2019 5y median -123.9% FY 2025
ROA -136.0%
FY 2019 5y median -136.0% FY 2025
Growth (YoY)
Revenue -34.2%
FY 2019 FY 2025
Operating Income -18.1%
FY 2019 FY 2025
EPS (diluted) 61.5%
FY 2019 FY 2025
Free Cash Flow -27.9%
FY 2019 FY 2025
Financial Health
Current Ratio 2.6×
FY 2019 5y median 1.8× FY 2025
Quick Ratio 2.6×
FY 2019 5y median 1.8× FY 2025
Debt / Equity 0.2×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA 0.4×
FY 2019 5y median 0.2× FY 2025
Interest Coverage -238×
FY 2019 5y median -96.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31